WO2001038580A3 - Nucleic acid probe arrays - Google Patents
Nucleic acid probe arrays Download PDFInfo
- Publication number
- WO2001038580A3 WO2001038580A3 PCT/US2000/032131 US0032131W WO0138580A3 WO 2001038580 A3 WO2001038580 A3 WO 2001038580A3 US 0032131 W US0032131 W US 0032131W WO 0138580 A3 WO0138580 A3 WO 0138580A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- anchor primer
- array
- target nucleic
- acid
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/682—Signal amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002392474A CA2392474A1 (en) | 1999-11-26 | 2000-11-27 | Nucleic acid probe arrays |
JP2001539921A JP2003515149A (en) | 1999-11-26 | 2000-11-27 | Nucleic acid probe array |
AU17927/01A AU783841B2 (en) | 1999-11-26 | 2000-11-27 | Nucleic acid probe arrays |
EP00980700A EP1234058A2 (en) | 1999-11-26 | 2000-11-27 | Nucleic acid probe arrays |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44940299A | 1999-11-26 | 1999-11-26 | |
US09/449,402 | 1999-11-26 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2001038580A2 WO2001038580A2 (en) | 2001-05-31 |
WO2001038580A3 true WO2001038580A3 (en) | 2002-04-25 |
WO2001038580A9 WO2001038580A9 (en) | 2002-12-05 |
Family
ID=23784034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/032131 WO2001038580A2 (en) | 1999-11-26 | 2000-11-27 | Nucleic acid probe arrays |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1234058A2 (en) |
JP (1) | JP2003515149A (en) |
AU (1) | AU783841B2 (en) |
CA (1) | CA2392474A1 (en) |
WO (1) | WO2001038580A2 (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2378245A (en) | 2001-08-03 | 2003-02-05 | Mats Nilsson | Nucleic acid amplification method |
US9388459B2 (en) * | 2002-06-17 | 2016-07-12 | Affymetrix, Inc. | Methods for genotyping |
US9487823B2 (en) | 2002-12-20 | 2016-11-08 | Qiagen Gmbh | Nucleic acid amplification |
US6977153B2 (en) * | 2002-12-31 | 2005-12-20 | Qiagen Gmbh | Rolling circle amplification of RNA |
EP1598427A1 (en) * | 2004-05-17 | 2005-11-23 | Charité - Universitätsmedizin Berlin | Method for the amplification of a target nucleic acid |
EP2471921A1 (en) | 2004-05-28 | 2012-07-04 | Asuragen, Inc. | Methods and compositions involving microRNA |
EP2302054B1 (en) | 2004-11-12 | 2014-07-16 | Asuragen, Inc. | Methods and compositions involving miRNA and miRNA inhibitor molecules |
SG162795A1 (en) | 2005-06-15 | 2010-07-29 | Callida Genomics Inc | Single molecule arrays for genetic and chemical analysis |
EP1762627A1 (en) | 2005-09-09 | 2007-03-14 | Qiagen GmbH | Method for the activation of a nucleic acid for performing a polymerase reaction |
US11306351B2 (en) | 2005-12-21 | 2022-04-19 | Affymetrix, Inc. | Methods for genotyping |
CA2663962A1 (en) | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Mir-15, mir-26, mir-31,mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention |
WO2008036765A2 (en) | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Micrornas differentially expressed in pancreatic diseases and uses thereof |
JP5719591B2 (en) | 2007-06-08 | 2015-05-20 | バイオジェン アイデック エムエー インコーポレイティドBiogen Idec Inc. | Biomarker for predicting anti-TNF responsiveness or non-responsiveness |
JP5020734B2 (en) * | 2007-07-31 | 2012-09-05 | 株式会社日立ハイテクノロジーズ | Nucleic acid analysis method and apparatus |
WO2009137807A2 (en) | 2008-05-08 | 2009-11-12 | Asuragen, Inc. | Compositions and methods related to mirna modulation of neovascularization or angiogenesis |
US8486630B2 (en) * | 2008-11-07 | 2013-07-16 | Industrial Technology Research Institute | Methods for accurate sequence data and modified base position determination |
GB0921264D0 (en) | 2009-12-03 | 2010-01-20 | Olink Genomics Ab | Method for amplification of target nucleic acid |
US10273544B2 (en) | 2010-02-11 | 2019-04-30 | Dana-Farber Cancer Institute, Inc. | Methods for predicting likelihood of responding to treatment |
WO2011108930A1 (en) | 2010-03-04 | 2011-09-09 | Interna Technologies Bv | A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT |
NZ719520A (en) | 2010-07-06 | 2017-07-28 | Int Tech Bv | Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway |
ES2629890T3 (en) | 2010-11-17 | 2017-08-16 | Interpace Diagnostics, Llc | miRNA as biomarkers to distinguish between benign and malignant thyroid neoplasms |
EP2474617A1 (en) | 2011-01-11 | 2012-07-11 | InteRNA Technologies BV | Mir for treating neo-angiogenesis |
WO2012158238A2 (en) | 2011-02-28 | 2012-11-22 | University Of Iowa Research Foundation | Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender |
CN102732598B (en) * | 2011-04-11 | 2017-03-01 | 陈先锋 | A kind of complete genome DNA sequence assembly sequence measurement |
EP2718866B1 (en) | 2011-06-07 | 2020-09-09 | Koninklijke Philips N.V. | Providing nucleotide sequence data |
WO2013040251A2 (en) | 2011-09-13 | 2013-03-21 | Asurgen, Inc. | Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease |
WO2013063519A1 (en) | 2011-10-26 | 2013-05-02 | Asuragen, Inc. | Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts |
US20130142728A1 (en) | 2011-10-27 | 2013-06-06 | Asuragen, Inc. | Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors |
EP2870263A1 (en) | 2012-07-03 | 2015-05-13 | InteRNA Technologies B.V. | Diagnostic portfolio and its uses |
US20140100124A1 (en) | 2012-10-04 | 2014-04-10 | Asuragen, Inc. | Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions |
KR101984700B1 (en) * | 2012-11-19 | 2019-05-31 | 삼성전자주식회사 | Polynucleotide and use thereof |
EP2970909A4 (en) | 2013-03-15 | 2017-02-15 | The University of Chicago | Methods and compositions related to t-cell activity |
WO2014151551A1 (en) | 2013-03-15 | 2014-09-25 | Baylor Research Institute | Ulcerative colitis (uc)-associated colorectal neoplasia markers |
EP2971132B1 (en) | 2013-03-15 | 2020-05-06 | Baylor Research Institute | Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer |
US11859246B2 (en) * | 2013-12-11 | 2024-01-02 | Accuragen Holdings Limited | Methods and compositions for enrichment of amplification products |
US11286519B2 (en) | 2013-12-11 | 2022-03-29 | Accuragen Holdings Limited | Methods and compositions for enrichment of amplification products |
EP3495506B1 (en) | 2013-12-11 | 2023-07-12 | AccuraGen Holdings Limited | Methods for detecting rare sequence variants |
WO2016156576A1 (en) | 2015-04-02 | 2016-10-06 | Hmnc Value Gmbh | Method of treatment using genetic predictors of a response to treatment with crhr1 antagonists |
CN108368545B (en) | 2015-10-09 | 2022-05-17 | 安可济控股有限公司 | Methods and compositions for enriching amplification products |
WO2017135383A1 (en) * | 2016-02-03 | 2017-08-10 | 国立大学法人豊橋技術科学大学 | Pseudo-circular double-stranded polynucleotide, and gene expression inhibitor using same |
US11427866B2 (en) | 2016-05-16 | 2022-08-30 | Accuragen Holdings Limited | Method of improved sequencing by strand identification |
SG11201901296TA (en) | 2016-08-15 | 2019-03-28 | Accuragen Holdings Ltd | Compositions and methods for detecting rare sequence variants |
EP3541950A4 (en) * | 2016-11-16 | 2020-06-03 | Progenity, Inc. | Multimodal assay for detecting nucleic acid aberrations |
US11497762B2 (en) | 2017-11-03 | 2022-11-15 | Interna Technologies B.V. | MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation |
US11203782B2 (en) | 2018-03-29 | 2021-12-21 | Accuragen Holdings Limited | Compositions and methods comprising asymmetric barcoding |
KR20210151944A (en) | 2019-04-12 | 2021-12-14 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | Compositions and methods for increasing muscle mass and oxidative metabolism |
WO2024028794A1 (en) | 2022-08-02 | 2024-02-08 | Temple Therapeutics BV | Methods for treating endometrial and ovarian hyperproliferative disorders |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5854033A (en) * | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
WO1999049079A1 (en) * | 1998-03-25 | 1999-09-30 | Ulf Landegren | Rolling circle replication of padlock probes |
WO1999053102A1 (en) * | 1998-04-16 | 1999-10-21 | Packard Bioscience Company | Analysis of polynucleotide sequence |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5503980A (en) * | 1992-11-06 | 1996-04-02 | Trustees Of Boston University | Positional sequencing by hybridization |
SE9701783D0 (en) * | 1997-05-14 | 1997-05-14 | Marek Kwiatkowski | In situ synthesis of oligonucleotides or inverse orientation |
US6280954B1 (en) * | 1998-02-02 | 2001-08-28 | Amersham Pharmacia Biotech Ab | Arrayed primer extension technique for nucleic acid analysis |
-
2000
- 2000-11-27 EP EP00980700A patent/EP1234058A2/en not_active Withdrawn
- 2000-11-27 JP JP2001539921A patent/JP2003515149A/en not_active Withdrawn
- 2000-11-27 AU AU17927/01A patent/AU783841B2/en not_active Ceased
- 2000-11-27 WO PCT/US2000/032131 patent/WO2001038580A2/en active IP Right Grant
- 2000-11-27 CA CA002392474A patent/CA2392474A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5854033A (en) * | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
WO1999049079A1 (en) * | 1998-03-25 | 1999-09-30 | Ulf Landegren | Rolling circle replication of padlock probes |
WO1999053102A1 (en) * | 1998-04-16 | 1999-10-21 | Packard Bioscience Company | Analysis of polynucleotide sequence |
Non-Patent Citations (3)
Title |
---|
HATCH A ET AL: "Rolling circle amplification of DNA immobilized on solid surfaces and its application to multiplex mutation detection", GENETIC ANALYSIS: BIOMOLECULAR ENGINEERING,ELSEVIER SCIENCE PUBLISHING,US, vol. 15, no. 2, April 1999 (1999-04-01), pages 35 - 40, XP004223009, ISSN: 1050-3862 * |
LIZARDI P M ET AL: "MUTATION DETECTION AND SINGLE-MOLECULE COUNTING USING ISOTHERMAL ROLLING-CIRCLE AMPLIFICATION", NATURE GENETICS,US,NEW YORK, NY, vol. 19, no. 3, July 1998 (1998-07-01), pages 225 - 232, XP000856939, ISSN: 1061-4036 * |
See also references of EP1234058A2 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001038580A2 (en) | 2001-05-31 |
WO2001038580A9 (en) | 2002-12-05 |
AU783841B2 (en) | 2005-12-15 |
JP2003515149A (en) | 2003-04-22 |
AU1792701A (en) | 2001-06-04 |
EP1234058A2 (en) | 2002-08-28 |
CA2392474A1 (en) | 2001-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001038580A3 (en) | Nucleic acid probe arrays | |
WO2001020039A3 (en) | Method of sequencing a nucleic acid | |
EP2308997A3 (en) | Detection of nucleic acids by type-specific hybrid capture method | |
WO1999005315A3 (en) | Nucleic acid sequence analysis | |
AU2001284295A1 (en) | Method of sequencing dna | |
EP0664339A4 (en) | Method of discriminating nucleic acid and testing set for discriminating nucleic acid. | |
WO2001077372A3 (en) | Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays | |
CA2244891A1 (en) | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays | |
WO1998002582A3 (en) | Methods for detecting and amplifying nucleic acid sequences using modified oligonucleotides having increased target specific t¿m? | |
AU1502395A (en) | Detection of nucleic acid amplification | |
EP1634966A3 (en) | Methods for detection of nucleic acid sequences in urine | |
AU2096192A (en) | Mycobacterium primers and probes | |
ATE188745T1 (en) | METHOD FOR DETECTING A NUCLIC ACID USING A NUCLIC ACID PROBE WHICH ALLOWS SPECIFIC CAPTURE AND DETECTION AT ONCE | |
WO2002048402A3 (en) | Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof | |
WO2000056927A3 (en) | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays | |
EP0718408A3 (en) | Sensitive method for detecting nucleic acids | |
WO2004059289A3 (en) | Target-dependent transcription using deletion mutants of n4 rna polymerase | |
BR9606602A (en) | Oligonucleotide amplification primer and method for complex complex amplification of an acid | |
WO2003083137A3 (en) | Detection of circularized immobilized nucleic acid probes | |
WO2004027081A3 (en) | Methods and composition for detecting targets | |
AUPO524897A0 (en) | Method of amplifying specific nucleic acid target sequences | |
EP0682121A4 (en) | Method of amplifying and detecting target nucleic acid sequence by using thermostable enzymes. | |
WO1996015264A3 (en) | Method for identifying nucleic acid sequences from different biological sources through amplification of the same | |
EP0950718A4 (en) | Method for detecting dna with probe pna | |
WO2005060618A3 (en) | Enzyme-free isothermal exponential amplification of nucleic acids and nucleic acid analog signals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2392474 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 539921 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 17927/01 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000980700 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000980700 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWG | Wipo information: grant in national office |
Ref document number: 17927/01 Country of ref document: AU |